Skip to main content
Premium Trial:

Request an Annual Quote

SelfDecode Raises Over $1M in Crowdfunding

NEW YORK – Precision health company SelfDecode has raised over $1 million in an ongoing crowdfunded investment round run through WeFunder, the firm said on Monday.

The company plans to use the funding to grow its research and development team and begin partnering with corporations with the aim of reducing healthcare costs via preventative treatments, providing clinical decision support systems to medical providers, and conducting clinical trials for FDA approval of patented diagnostic tests.

SelfDecode said it builds genomic models by analyzing DNA and environmental factors with deep learning, Bayesian machine learning, and hyperdimensional computing methods. The company uses the resulting models to deliver personalized health recommendations.

"We are ecstatic to see such excitement from individual investors who recognize the accomplishments that SelfDecode has realized and believe in what we are building," Joe Cohen, SelfDecode's founder and CEO, said in a statement.

In addition to DNA testing, SelfDecode offers health and lifestyle recommendations based on medical lab results uploaded by users.

The company said it had nearly $2.5 million in revenue over the past year and 14,500 active, paid members.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.